Awards to the Institution
| Funding | |||
|---|---|---|---|
| Disease Team Research I: | Allan Robins | Cell Therapy for Diabetes | $22,999,937 |
| Tools and Technologies I: | Evert Kroon | Development of the Theracyte Cellular Encapsulation System for Delivery of human ES Cell-derived Pancreatic Islets and Progenitors. | $827,072 |
| Early Translational I: | Olivia Kelly | Methods for detection and elimination of residual human embryonic stem cells in a differentiated cell product | $5,405,397 |
| Strategic Partnership I: | Howard Foyt | Preclinical and clinical testing of a stem cell-based combination product for insulin-dependent diabetes | $10,075,070 |
| Disease Team Planning: | Emmanuel Baetge | Development of a Cell Replacement Therapy Product for Insulin Dependent Diabetes | $48,950 |
Total: $39,356,426.00 |
